Qnovia announced that it raised $16 million in Series B funding to support its inhaled smoking cessation therapy platform.

The funding will primarily be allocated toward the submission of an application to British regulators to allow for the ...

Wendy Clark, from Sudbury, Suffolk, had been smoking for 43 years before she had a heart attack in September. She was warned ...

Qnovia, Inc., a pharmaceutical company who recently announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for the RespiRx™ Nicotine ...

Qnovia, Inc., a pharmaceutical company who recently announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for the RespiRxtm Nicotine ...

Qnovia, a Richmond startup focused on smoking-cessation technology, has raised $16 million in a Series B round.

After over 12 Years of innovation and immense success in the health & wellness industry from the THRIVE Experience and THRIVE ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

Aug. 8, 2024 — A new study suggests that cannabis, the most commonly used illicit substance worldwide, is associated with an increased occurrence of head and neck ... New Study Finds 40-Percent ...

Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and ...

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I’m dealing with the effects of it ...

Asthma tends to run in families, says Dr. Manav Singla, MD, an allergist and immunologist at MedStar Health in Baltimore: ...